The UC Cures for Alzheimer’s Disease Initiative awards focuses on funding “cutting-edge projects primed for clinical trial,” officials said Monday.
One project will be led by UC Irvine and the other by UC San Francisco. The grant is for $1 million annually for two years.
“As a premier public research university with dedicated faculty and a wealth of resources, we are uniquely positioned to take on the seemingly insurmountable challenge of Alzheimer’s disease,” UC President Janet Napolitano said.
“These impressive projects focus our efforts on finding effective treatments for one of the most terrible, pervasive diseases of our time,” she added.
Joshua Grill, a UCI associate professor, will lead a team studying the effects of large doses of vitamin nicotinamide in helping those afflicted with Alzheimer’s.
—City News Service
>> Want to read more stories like this? Get our Free Daily Newsletters Here!Follow us: